Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Pharma spent almost $3 billion on TV advertising in the first six months

The news: Prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, an increase of 12.2% YoY, per iSpot.tv.

Digging into the data: Pharma companies increased spending on linear TV media, primarily among those selling diabetes and weight loss drugs.

  • Diabetes and blood disorder drugmakers spent the most ($568.8 million) on linear TV ads. Four GLP-1 brands (Wegovy, Ozempic, Zepbound, and Mounjaro) accounted for $413.2 million of the total.
  • Psoriasis, shingles, and skin & nail prescription drugs were next with $430 million spent.
  • Bladder and gastrointestinal conditions accounted for third-highest spending at $392.5 million.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account